Global Presence
Research for better medicines
At MSN Laboratories, our journey in Research and Development (R&D) began in 2003 with a mission to develop the highest quality generic medicines at the most affordable cost. By integrating Active Pharmaceutical Ingredient (API) and Formulation R&D under one roof, we have revolutionized pharmaceutical development with excellence, speed, and precision.
Our R&D Facility: The Heart of MSN Labs
Our fully integrated R&D center, established in 2012, spans a sprawling 750,000 sq. ft., One of Asia's largest R&D centers serves as the epicenter for breakthrough pharmaceutical research.
State of the Art Infrastructure
- State-of-the-Art Infrastructure
- Cutting-edge technology platforms.
- Robust facilities for analysis and product development
Expert Workforce
- 2,200+ scientists and experts dedicated to innovation.
- Specialists in formulation development, method development, and lifecycle management.
Core R&D Capabilities
<
>
- Complex APIs & Formulations
- Oligonucleotides
- Complex Peptides
- NCEs
- Novel Drug Delivery System (NDDS)
- Niche Generics
- 1000+ Patents
- World’s No.1 US DMF Filers
- 1250 Drug Master Files (DMFs).
- 2,400+ Dossiers.
- 170+ ANDAs registered.
- Continuous quality improvements and compliance with evolving regulatory standards.
